Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Psychiatr Serv. 2015 Nov 16;67(3):302–309. doi: 10.1176/appi.ps.201500088

Figure 1.

Figure 1

Proportion of children, young adults, and adults initiating SSRI treatment on a low dose

BBW = Black-box warning

Low dose = 5–12 years (<10mg/d citalopram, fluoxetine, and paroxetine immediate release and <25mg/d sertraline); 13–17 years (<20mg/d citalopram and fluoxetine, <10mg/d paroxetine immediate release, and <50mg/d sertraline); 18–64 years (<20mg/d citalopram, fluoxetine, and paroxetine immediate release, <25mg/d paroxetine controlled release, and <50mg/d sertraline); Children 5–17 years: paroxetine controlled release unavailable <12.5mg/d